Results 61 to 67 of about 306 (67)
Leveraging increased cytoplasmic nucleoside kinase activity to target mtDNA and oxidative phosphorylation in AML.
Blood, 2017 Liyanage SU, Hurren R, Voisin V, Bridon G, Wang X, Xu C, MacLean N, Siriwardena TP, Gronda M, Yehudai D, Sriskanthadevan S, Avizonis D, Shamas-Din A, Minden MD, Bader GD, Laposa R, Schimmer AD. +16 moreeuropepmc +1 more sourceChronic lysosome damage boosts interferon responses to Palbociclib dependent upon the mitochondrion
Bozic M, Lim TE, Salomó-Coll C, Karageorgiou A, Kemp AJ, Winnington-Ingram K, Murphy L, Dhir A, Wheeler A, Jimenez-Moreno N, Wilkinson S. +10 moreeuropepmc +1 more sourceMultimodal decoding of human liver regeneration. [PDF]
NatureMatchett KP, Wilson-Kanamori JR, Portman JR, Kapourani CA, Fercoq F, May S, Zajdel E, Beltran M, Sutherland EF, Mackey JBG, Brice M, Wilson GC, Wallace SJ, Kitto L, Younger NT, Dobie R, Mole DJ, Oniscu GC, Wigmore SJ, Ramachandran P, Vallejos CA, Carragher NO, Saeidinejad MM, Quaglia A, Jalan R, Simpson KJ, Kendall TJ, Rule JA, Lee WM, Hoare M, Weston CJ, Marioni JC, Teichmann SA, Bird TG, Carlin LM, Henderson NC. +35 moreeuropepmc +1 more sourceA Novel POR G88S Mutation Causes Severe PORD and Establishes a Critical Pharmacogenomic Risk Profile.
J Clin Endocrinol MetabRojas Velazquez MN, Lopez Dacal J, Jørgensen FS, Sanguineti N, Sharma K, Marino R, Pérez Garrido N, Vaiani E, Ramírez P, Scaglia P, Izquierdo A, Sansó G, Ropelato MG, Bergadá I, Rey RA, Grinspon RP, Pandey AV. +16 moreeuropepmc +1 more source
